Literature DB >> 20233002

Prediction of marginal mass required for successful islet transplantation.

Klearchos K Papas1, Clark K Colton, Andi Qipo, Haiyan Wu, Rebecca A Nelson, Bernhard J Hering, Gordon C Weir, Maria Koulmanda.   

Abstract

Islet quality assessment methods for predicting diabetes reversal (DR) following transplantation are needed. We investigated two islet parameters, oxygen consumption rate (OCR) and OCR per DNA content, to predict transplantation outcome and explored the impact of islet quality on marginal islet mass for DR. Outcomes in immunosuppressed diabetic mice were evaluated by transplanting mixtures of healthy and purposely damaged rat islets for systematic variation of OCR/DNA over a wide range. The probability of DR increased with increasing transplanted OCR and OCR/DNA. On coordinates of OCR versus OCR/DNA, data fell into regions in which DR occurred in all, some, or none of the animals with a sharp threshold of around 150-nmol/min mg DNA. A model incorporating both parameters predicted transplantation outcome with sensitivity and specificity of 93% and 94%, respectively. Marginal mass was not constant, depended on OCR/DNA, and increased from 2,800 to over 100,000 islet equivalents/kg body weight as OCR/DNA decreased. We conclude that measurements of OCR and OCR/DNA are useful for predicting transplantation outcome in this model system, and OCR/DNA can be used to estimate the marginal mass required for reversing diabetes. Because human clinical islet preparations in a previous study had OCR/DNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233002      PMCID: PMC3786417          DOI: 10.3109/08941930903410825

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  29 in total

Review 1.  Selected Food and Drug Administration review issues for regulation of allogeneic islets of langerhans as somatic cell therapy.

Authors:  Darin J Weber; Richard D McFarland; Ilan Irony
Journal:  Transplantation       Date:  2002-12-27       Impact factor: 4.939

2.  In vivo use of monoclonal antibodies against murine T cell antigens.

Authors:  R R Ghobrial; M Boublik; H J Winn; H Auchincloss
Journal:  Clin Immunol Immunopathol       Date:  1989-09

3.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

4.  Clinical islet transplantation: guidelines for islet quality control.

Authors:  R G Bretzel; R Alejandro; B J Hering; P T van Suylichem; C Ricordi
Journal:  Transplant Proc       Date:  1994-04       Impact factor: 1.066

5.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Cell loss in isolated human islets occurs by apoptosis.

Authors:  S Paraskevas; D Maysinger; R Wang; T P Duguid; L Rosenberg
Journal:  Pancreas       Date:  2000-04       Impact factor: 3.327

7.  Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets.

Authors:  Adam Frank; Shaoping Deng; Xiaolun Huang; Ergun Velidedeoglu; Yong-Suk Bae; Chengyang Liu; Peter Abt; Robert Stephenson; Muhammad Mohiuddin; Thav Thambipillai; Eileen Markmann; Maral Palanjian; Marty Sellers; Ali Naji; Clyde F Barker; James F Markmann
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  A stirred microchamber for oxygen consumption rate measurements with pancreatic islets.

Authors:  Klearchos K Papas; Anna Pisania; Haiyan Wu; Gordon C Weir; Clark K Colton
Journal:  Biotechnol Bioeng       Date:  2007-12-01       Impact factor: 4.530

9.  Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats.

Authors:  Juan L Contreras; Christopher Eckstein; Cheryl A Smyth; Marty T Sellers; Mario Vilatoba; Guadalupe Bilbao; Firoz G Rahemtulla; Carlton J Young; J Anthony Thompson; Irshad H Chaudry; Devin E Eckhoff
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

10.  Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors.

Authors:  Devin E Eckhoff; Christopher Eckstein; Cheryl A Smyth; Mario Vilatoba; Guadalupe Bilbao; Firoz G Rahemtulla; Carlton J Young; J Anthony Thompson; Irshad H Chaudry; Juan L Contreras
Journal:  Surgery       Date:  2004-08       Impact factor: 3.982

View more
  22 in total

1.  Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device.

Authors:  M M Coronel; J-P Liang; Y Li; C L Stabler
Journal:  Biomaterials       Date:  2019-04-19       Impact factor: 12.479

2.  Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.

Authors:  Barbara Ludwig; Avi Rotem; Janine Schmid; Gordon C Weir; Clark K Colton; Mathias D Brendel; Tova Neufeld; Norman L Block; Karina Yavriyants; Anja Steffen; Stefan Ludwig; Triantafyllos Chavakis; Andreas Reichel; Dimitri Azarov; Baruch Zimermann; Shiri Maimon; Mariya Balyura; Tania Rozenshtein; Noa Shabtay; Pnina Vardi; Konstantin Bloch; Paul de Vos; Andrew V Schally; Stefan R Bornstein; Uriel Barkai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

3.  Islet preparation purity is overestimated, and less pure fractions have lower post-culture viability before clinical allotransplantation.

Authors:  J P Kitzmann; T Karatzas; K R Mueller; E S Avgoustiniatos; A C Gruessner; A N Balamurugan; M D Bellin; B J Hering; K K Papas
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

4.  Islet oxygen consumption rate dose predicts insulin independence for first clinical islet allotransplants.

Authors:  J P Kitzmann; D O'Gorman; T Kin; A C Gruessner; P Senior; S Imes; R W Gruessner; A M J Shapiro; K K Papas
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

5.  Metabolic profile of pancreatic acinar and islet tissue in culture.

Authors:  T M Suszynski; K R Mueller; A C Gruessner; K K Papas
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

6.  Quantitative assessment of islets of Langerhans encapsulated in alginate.

Authors:  Amy S Johnson; Esther O'Sullivan; Laura N D'Aoust; Abdulkadir Omer; Susan Bonner-Weir; Robert J Fisher; Gordon C Weir; Clark K Colton
Journal:  Tissue Eng Part C Methods       Date:  2011-01-16       Impact factor: 3.056

7.  Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin.

Authors:  Kate R Mueller; A N Balamurugan; Gary W Cline; Rebecca L Pongratz; Rebecca L Hooper; Bradley P Weegman; Jennifer P Kitzmann; Michael J Taylor; Melanie L Graham; Henk-Jan Schuurman; Klearchos K Papas
Journal:  Xenotransplantation       Date:  2013-02-05       Impact factor: 3.907

Review 8.  Islet assessment for transplantation.

Authors:  Klearchos K Papas; Thomas M Suszynski; Clark K Colton
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

9.  Islet size index as a predictor of outcomes in clinical islet autotransplantation.

Authors:  Thomas M Suszynski; Joshua J Wilhelm; David M Radosevich; A N Balamurugan; David E R Sutherland; Gregory J Beilman; Ty B Dunn; Srinath Chinnakotla; Timothy L Pruett; Selwyn M Vickers; Bernhard J Hering; Klearchos K Papas; Melena D Bellin
Journal:  Transplantation       Date:  2014-06-27       Impact factor: 4.939

10.  Manufacturing porcine islets: culture at 22 °C has no advantage above culture at 37 °C: a gene expression evaluation.

Authors:  Kate R Mueller; Kyra V Martins; Michael P Murtaugh; Henk-Jan Schuurman; Klearchos K Papas
Journal:  Xenotransplantation       Date:  2013-08-14       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.